A Study of ARRY-380 in Patients With Advanced HER2+ Cancer
Clinical trial NCT00650572 · COMPLETED
Trial details
- NCT number
- NCT00650572
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2013-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.